NetworkNewsBreaks – Avricore Health Inc. (TSX.V:
Post# of 61
(Total Views: 255)
Posted On: 10/26/2021 3:47:37 PM
NetworkNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Announces Expansion of HealthTab Patient Testing in Select Shoppers Drug Mart Locations
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward, has launched its HealthTab(TM) platform in various Shoppers Drug Mart(R) pharmacies located throughout British Columbia. This move marks the first time the company’s diabetes screening program has been available in Western Canada. Avricore signed a master agreement with Shoppers Drug Mart Inc. earlier this year. That agreement involved a pilot program that provided patients with access to point-of-care blood screening and health-data management for potential risks for developing diabetes and cardiovascular conditions. Those services were offered through AVCRF’s HealthTab-integrated Afinion 2(TM) analyzers by Abbott Rapid Diagnostics. Based on the positive feedback from both patients and pharmacists, Shoppers Drug Mart began looking for ways that more patients could benefit from the service. This new agreement is one of those ways. “The launch in Shoppers Drug Mart pharmacies in Ontario has been very successful, and we are very happy to see the program lay the groundwork for expansion,” said Avricore Health CEO Hector Bremner in the press release. “Having a real-time patient observation program reporting seamlessly across 3000kms is very unique, and we are very proud to deliver this innovation.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward, has launched its HealthTab(TM) platform in various Shoppers Drug Mart(R) pharmacies located throughout British Columbia. This move marks the first time the company’s diabetes screening program has been available in Western Canada. Avricore signed a master agreement with Shoppers Drug Mart Inc. earlier this year. That agreement involved a pilot program that provided patients with access to point-of-care blood screening and health-data management for potential risks for developing diabetes and cardiovascular conditions. Those services were offered through AVCRF’s HealthTab-integrated Afinion 2(TM) analyzers by Abbott Rapid Diagnostics. Based on the positive feedback from both patients and pharmacists, Shoppers Drug Mart began looking for ways that more patients could benefit from the service. This new agreement is one of those ways. “The launch in Shoppers Drug Mart pharmacies in Ontario has been very successful, and we are very happy to see the program lay the groundwork for expansion,” said Avricore Health CEO Hector Bremner in the press release. “Having a real-time patient observation program reporting seamlessly across 3000kms is very unique, and we are very proud to deliver this innovation.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Avricore Health Inc. (AVCRF) Stock Research Links
Scroll down for more posts ▼